| Bioactivity | DRI-C21041 is a CD40/CD40L interaction inhibitor, with an IC50 of 0.31 μM. DRI-C21041 inhibits the immune response induced by alloantigen[1]. |
| Invitro | DRI-C21041 抑制 CD40L 诱导的 B 细胞活化、增殖和 NF-κB 的活化[1]。 |
| Name | DRI-C21041 |
| CAS | 2101765-78-8 |
| Formula | C30H21N3O7S |
| Molar Mass | 567.57 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lu H, et, al. Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020 Sep 23;5(1):213. |
DRI-C21041
CAS: 2101765-78-8 F: C30H21N3O7S W: 567.57
DRI-C21041 is a CD40/CD40L interaction inhibitor, with an IC50 of 0.31 μM. DRI-C21041 inhibits the immune response indu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.